CD47-SIRPalpha interaction inhibitor (Blacksmith Medicines)

N/A

Report date: 2025/06/11 10:48:58
NME

Base Information

Drug NameCD47-SIRPalpha interaction inhibitor (Blacksmith Medicines)
Drug Alias NameCD47 checkpoint inhibitor (Blacksmith Medicines)QPCTL inhibitor (Blacksmith Medicines)
ClassificationSmall molecules
Mechanisms of ActionCluster of differentiation 47 inhibitorsGlutaminyl-peptide cyclotransferase inhibitorsAngiogenesis modulators +[5] 
TargetsGlutaminyl-peptide cyclotransferaseCluster of differentiation 47
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlacksmith Medicines Inc
China Registration ClassN/A

Develop Information

Active CompaniesBlacksmith Medicines Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A